Literature DB >> 31478635

Venous Ulcers: Diagnosis and Treatment.

Susan Bonkemeyer Millan1, Run Gan2, Petra E Townsend1.   

Abstract

Venous ulcers are the most common type of chronic lower extremity ulcers, affecting 1% to 3% of the U.S. population. Venous hypertension as a result of venous reflux (incompetence) or obstruction is thought to be the primary underlying mechanism for venous ulcer formation. Risk factors for the development of venous ulcers include age 55 years or older, family history of chronic venous insufficiency, higher body mass index, history of pulmonary embolism or superficial/deep venous thrombosis, lower extremity skeletal or joint disease, higher number of pregnancies, parental history of ankle ulcers, physical inactivity, history of ulcers, severe lipodermatosclerosis, and venous reflux in deep veins. Poor prognostic signs for healing include ulcer duration longer than three months, initial ulcer length of 10 cm or more, presence of lower limb arterial disease, advanced age, and elevated body mass index. On physical examination, venous ulcers are generally irregular and shallow with well-defined borders and are often located over bony prominences. Signs of venous disease, such as varicose veins, edema, or venous dermatitis, may be present. Other associated findings include telangiectasias, corona phlebectatica, atrophie blanche, lipodermatosclerosis, and inverted champagne-bottle deformity of the lower leg. Chronic venous ulcers significantly impact quality of life. Severe complications include infection and malignant change. Current evidence supports treatment of venous ulcers with compression therapy, exercise, dressings, pentoxifylline, and tissue products. Referral to a wound subspecialist should be considered for ulcers that are large, of prolonged duration, or refractory to conservative measures. Early venous ablation and surgical intervention to correct superficial venous reflux can improve healing and decrease recurrence rates.

Entities:  

Mesh:

Year:  2019        PMID: 31478635

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  6 in total

1.  Suggestions for a New Clinical Classification Approach to Panniculitis Based on a Mayo Clinic Experience of 207 Cases.

Authors:  Nimay C Anand; Mika Takaichi; Emma F Johnson; David A Wetter; Mark D P Davis; Afsaneh Alavi
Journal:  Am J Clin Dermatol       Date:  2022-07-18       Impact factor: 6.233

Review 2.  Management of Lower Extremity Pain from Chronic Venous Insufficiency: A Comprehensive Review.

Authors:  Vwaire Orhurhu; Robert Chu; Katherine Xie; Ghislain N Kamanyi; Bisola Salisu; Mariam Salisu-Orhurhu; Ivan Urits; Rachel J Kaye; Jamal Hasoon; Omar Viswanath; Aaron J Kaye; Jay Karri; Zwade Marshall; Alan D Kaye; Dua Anahita
Journal:  Cardiol Ther       Date:  2021-03-11

3.  Discriminating Reflux from Non-Reflux Diseases of Superficial Veins in Legs by Novel Non-Contrast MR with QFlow Technique.

Authors:  Yuan-Hsi Tseng; Chien-Wei Chen; Min Yi Wong; Teng-Yao Yang; Bor-Shyh Lin; Hua Ting; Yao-Kuang Huang
Journal:  J Pers Med       Date:  2021-03-26

4.  Nonhealing venous ulcer in a patient with dystrophic soft tissue calcification.

Authors:  Abdullah Nasif; Karen Bauer; Vanessa Pasadyn; Ayman Ahmed; Munier Nazzal; Mohamed Osman
Journal:  J Vasc Surg Cases Innov Tech       Date:  2022-03-04

5.  Radiofrequency ablation of varicose veins in combination with ultrasonic-assisted wound debridement and platelet-rich plasma as well as platelet-rich fibrin technologies in treatment of lower extremity venous ulcers in office-based surgery.

Authors:  Volodymyr Goshchynsky; Yrij Svidersky; Bogdan Migenko; Oleg Pyatnychka
Journal:  Pan Afr Med J       Date:  2022-06-24

6.  Physical Activity as an Adjunct to Compression Therapy on Healing Outcomes and Recurrence in Patients With Venous Leg Ulcers: A Scoping Review Protocol.

Authors:  Yunjing Qiu; Christian Robert Osadnik; Victoria Team; Carolina Dragica Weller
Journal:  Front Med (Lausanne)       Date:  2021-07-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.